All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.
During the 18th International Myeloma Workshop, the Multiple Myeloma Hub spoke with Hermann Einsele, Julius-Maximilians-Universität Würzburg, Würzburg, DE. He discussed the top five communications from the 18th International Myeloma Workshop (IMW).
My top 5 communications from the 18th IMW
Einsele discusses new advances, including the CARTITUDE-1 (NCT03548207) trial, and new immunotherapeutic strategies presented in the IMW.
Your opinion matters
Hermann Einsele | EBMT 2019 | CAR T therapy versus targeted antibodies in multiple myeloma
Hermann Einsele | EBMT 2019 | CAR T therapy versus targeted antibodies in multiple myeloma. University Hospital of Würzburg, Würzburg, DE
CAR T Cell Meeting 2019 | CAR T in multiple myeloma: when to use CAR T
On February 14, 2019, Professor Hermann Einsele, University Hospital Würzburg, Germany, presented at the 1st European CAR T Cell Meeting in Paris, France
Subscribe to get the best content related to multiple myeloma delivered to your inbox